Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration

Several disease-modulatory FDA-approved drugs are being used in patients with neurodegenerative diseases. However, information on their toxicity-related profiles is very limited. Therefore, measurement of drug toxicity is essential to increase the knowledge of their side effects. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Ankita, Zeng, Xin-An, Rahaman, Abdul, Farooq, Muhammad Adil, Huang, Yanyan, Alee, Mahafooj, Yao, Runyu, Ali, Murtaza, Khalifa, Ibrahim, Badr, Omnia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637979/
https://www.ncbi.nlm.nih.gov/pubmed/36353729
http://dx.doi.org/10.3389/fmolb.2022.984461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637979/
https://www.ncbi.nlm.nih.gov/pubmed/36353729
http://dx.doi.org/10.3389/fmolb.2022.984461

Ejemplares similares